Intranasal calcitonin is given for a 65 year old post-menopausal lady. What is the likely indication?
Calcitonin-salmon is a hormone that decreases osteoclast activity, thereby impeding postmenopausal bone loss. It is indicated for the treatment of women who are more than 5 years post menopause and have low bone mass relative to healthy premenopausal women. It is available as an injection and as an intranasal spray. The intranasal spray is delivered as a single daily spray that provides 200 IU of the drug.
Paget's disease
Osteoporosis
Hypercalcemia
Osteopetrosis